Quest Diagnostics IncorporatedDGXNYSE
Loading
Cash Generation ExpandingExpanding
Percentile Rank86
3Y CAGR+1.1%
5Y CAGR-3.1%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+1.1%/yr
vs +12.6%/yr prior
5Y CAGR
-3.1%/yr
Recent acceleration
Acceleration
-11.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.36B | +49.5% |
| 2024 | $909.00M | +5.2% |
| 2023 | $864.00M | -34.2% |
| 2022 | $1.31B | -28.2% |
| 2021 | $1.83B | +15.3% |
| 2020 | $1.59B | +88.3% |
| 2019 | $843.00M | +3.2% |
| 2018 | $817.00M | -11.5% |
| 2017 | $923.00M | +18.9% |
| 2016 | $776.00M | - |